A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
about
Vaccines for preventing herpes zoster in older adultsVaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsVaccines for preventing herpes zoster in older adultsVaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsPneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageVZV meningitis following varicella vaccine.Varicella vaccination--a critical review of the evidence.Vaccination to prevent varicella and shingles.Prevention of shingles by varicella zoster virus vaccination.Vaccination in the elderly: what can be recommended?Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen.Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.Responder cell frequency estimation and binomial three-level nonlinear mixed effects model in limiting dilution assays.Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis
P2860
Q24186050-F629933B-A566-491C-BCD7-5236A9985E42Q24193819-67B8E691-6D47-4A7D-9AE4-91212A996097Q24198256-EC9F357D-B573-4C09-96B6-332E46FE5258Q24242809-4BC9E258-A80C-46A8-BCC6-A3F2820EFF13Q24245934-2BFFAC0B-C768-4BCC-AD88-FAC8C9547C90Q33562815-D9F2F014-BAC9-4093-B477-9F9E49AEDFA8Q34315355-848512B6-C313-41CA-B482-732F6A742E4EQ35397475-EE85C429-E92E-45B5-B214-629AC8A58E20Q36600317-FFEF4200-4A63-4E08-8303-55AABB1C00A4Q38220158-13457834-E8E6-407A-8767-399562E36216Q39508564-D95F142D-BA42-4D86-82ED-FCA4AE60A4C2Q42149711-547DED6E-B4A8-408B-B50E-BF06C09864E8Q43613106-35A19C3F-8630-4706-9B79-05B703E6BF58Q44568321-1D8F7587-360A-40E0-BFC3-22F6D8B04C9BQ52973209-8D8AF24A-BD0A-49BA-9D77-3911818CCB6CQ58553251-D4624C60-5016-4363-B607-2EF450B46D29
P2860
A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
A dose-response study of a liv ...... lts 55 years of age and older.
@en
A dose-response study of a live attenuated varicella-zoster virus
@nl
type
label
A dose-response study of a liv ...... lts 55 years of age and older.
@en
A dose-response study of a live attenuated varicella-zoster virus
@nl
prefLabel
A dose-response study of a liv ...... lts 55 years of age and older.
@en
A dose-response study of a live attenuated varicella-zoster virus
@nl
P2093
P356
P1476
A dose-response study of a liv ...... lts 55 years of age and older.
@en
P2093
P304
P356
10.1086/514265
P407
P478
178 Suppl 1
P577
1998-11-01T00:00:00Z